Skip to main content

DEUTSCHE BANK AG\

Bank

Position in AVXL — Anavex Life Sciences Corp.

CIK 948046 FRANKFURT AM MAIN, 2M

Position in AVXL

as of Mar 31, 2026 · filed May 6, 2026
Position Value
$229,927
-$17,659 QoQ
Shares Held
74,895
+7.7% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 2% Shared 0% None 98%

Common Shares in AVXL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

DEUTSCHE BANK AG\ holds $2,976,719,496 across 248 Biotechnology names. AVXL ranks #200 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AVXL

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $229,927 74,895
2025-12-31 $247,586 69,547
2025-09-30 $646,798 72,674
2025-06-30 $568,836 61,696
2025-03-31 $507,755 59,179
2024-12-31 $693,202 64,544
2024-09-30 $224,472 39,520
2024-06-30 $105,470 24,993
2024-03-31 $192,274 37,775
2023-12-31 $377,622 40,561
2023-09-30 $248,107 37,879
2023-06-30 $281,777 34,659
2023-03-31 $431,293 50,326
2022-12-31 $382,428 41,299
2022-09-30 $308,123 29,857
2022-06-30 $1,499,467 149,797
2022-03-31 $1,900,650 154,399
2021-12-31 $2,734,795 157,716
2021-09-30 $2,778,317 154,781
2021-06-30 $3,536,830 154,717
2021-03-31 $592,228 39,614
2020-12-31 $214,093 39,647
2020-09-30 $131,244 28,845
2020-06-30 $129,750 26,372
2020-03-31 $58,076 18,437